Clinical Trials

Privado Health

Privado Health is committed to being at the forefront of cancer treatment using Theranostics. Dr Frankis Almaguel, is a leader in his field of Nuclear Oncology and Molecular Imaging, he has been deeply involved in the research surrounding cancer treatments using theranostics. Dr. Almaguel continues to successfully perform clinical trials across many different types of cancer.

Phase 1

Test new drugs for the first time in a small group of people to evaluate a safe dosage range and identify any side effects.

Phase 2

Test treatments that have been found to be safe in Phase I and are ready for a larger group of human subjects to monitor for adverse effects.

III

Phase 3

Study to be conducted on larger populations and in different regions and countries, this is the step right before a new treatment is approved.

Phase 4

Studies take place post approval, however, there is still a need for further testing in a wide population over a longer timeframe.

theranostics clinical trials

What are Clinical Trials?

Clinical trials follow a specific set of protocols, this detailed plan outlines the study's objectives, design, methodology, and other crucial details. Participants in clinical trials are volunteers who may have the condition being studied or may be healthy individuals. Before participating, individuals must provide informed consent, be fully informed about the trial's purpose, risks, and potential benefits. The results of clinical trials contribute to the body of scientific knowledge and help healthcare professionals make informed decisions about the best treatments for their patients.

Our Constant Pursuit for Excellence

Privado Health is developing clinical trials in partnership with international pharmaceutical companies to pursue additional cancer treatment options forr various types of cancer affecting people around the world.